Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Cole Douglas G. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 4 Cole Douglas G. (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Disposed/sold 683 options to buy @ $6.6439, valued at $4.5k
Disposed/sold 683 options to buy @ $4.9984, valued at $3.4k
06/09/2023 4 Cole Douglas G. (Director) has filed a Form 4 on Sana Biotechnology, Inc.
Txns: Granted 65,000 options to buy @ $6.7, valued at $435.5k
06/05/2023 4 Cole Douglas G. (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Granted 4,216 shares @ $0
Granted 12,649 options to buy @ $30.92, valued at $391.1k
06/22/2022 4 Cole Douglas G. (Director) has filed a Form 4 on Foghorn Therapeutics Inc.
Txns: Granted 16,000 options to buy @ $13.81, valued at $221k
06/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Cole Douglas G. (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 8,888 options to buy @ $0.7632, valued at $6.8k
07/14/2021 4 Cole Douglas G. (Director) has filed a Form 4 on Foghorn Therapeutics Inc.
Txns: Granted 12,530 options to buy @ $9.4, valued at $117.8k
06/28/2021 4 Cole Douglas G. (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Granted 8,888 options to buy @ $9.97, valued at $88.6k
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2021 4 Cole Douglas G. (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Exercised 3,253 restricted stock units @ $0
02/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/05/2020 4 Cole Douglas G. (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Granted 15,183 options to buy @ $28.82, valued at $437.6k
Granted 3,253 restricted stock units @ $0
05/31/2019 4 Cole Douglas G. (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Granted 27,245 options to buy @ $19.5, valued at $531.3k
01/04/2019 4 Cole Douglas G. (Director) has filed a Form 4 on Quanterix Corp
Txns: Granted 2,270 shares @ $0
Granted 7,900 options to buy @ $18.24, valued at $144.1k
08/09/2018 4 Cole Douglas G. (Director) has filed a Form 4 on Quanterix Corp
Txns: Granted 2,270 shares @ $0
Granted 7,900 options to buy @ $14.8, valued at $116.9k
06/15/2018 4 Cole Douglas G. (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Granted 27,830 options to buy @ $18.92, valued at $526.5k
12/08/2017 4 Cole Douglas G. (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Granted 47,165 options to buy @ $18, valued at $849k
08/21/2017 4 Cole Douglas G. (Director) has filed a Form 4 on Editas Medicine, Inc.
Txns: Acquired 1,686 shares @ $0
06/19/2017 4 Cole Douglas G. (Director) has filed a Form 4 on Editas Medicine, Inc.
Txns: Granted 11,538 options to buy @ $15.63, valued at $180.3k
08/11/2016 4 Cole Douglas G. (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS INC
Txns: Acquired 917 shares @ $0
06/23/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/25/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
06/25/2014 4 Cole Douglas G. (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS INC
Txns: Acquired 1,861 shares @ $0
06/05/2014 4 Cole Douglas G. (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS INC
Txns: Granted 12,500 options to buy @ $35.16, valued at $439.5k
07/19/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
03/27/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
05/16/2011 4 Cole Douglas G. (Director) has filed a Form 4 on AVEO PHARMACEUTICALS INC
Txns: Sold 919 shares @ $17.3033, valued at $15.9k
Sold 15,200 shares @ $17.3033, valued at $263k
Sold 4,639 shares @ $17.7517, valued at $82.4k
Sold 76,750 shares @ $17.7518, valued at $1.4M
Sold 2,992 shares @ $17.9772, valued at $53.8k
Sold 49,500 shares @ $17.9773, valued at $889.9k
01/03/2011 4 Cole Douglas G. (Director) has filed a Form 4 on AVEO PHARMACEUTICALS INC
Txns: Sold 370 shares @ $14.6212, valued at $5.4k
Sold 6,130 shares @ $14.6212, valued at $89.6k
Sold 1,109 shares @ $14.5564, valued at $16.1k
Sold 18,384 shares @ $14.5564, valued at $267.6k
Sold 364 shares @ $14.5304, valued at $5.3k
Sold 6,036 shares @ $14.5304, valued at $87.7k
12/29/2010 4 Cole Douglas G. (Director) has filed a Form 4 on AVEO PHARMACEUTICALS INC
Txns: Sold 555 shares @ $14.623, valued at $8.1k
Sold 9,180 shares @ $14.623, valued at $134.2k
Sold 804 shares @ $14.4967, valued at $11.7k
Sold 13,308 shares @ $14.4967, valued at $192.9k
12/27/2010 4 Cole Douglas G. (Director) has filed a Form 4 on AVEO PHARMACEUTICALS INC
Txns: Sold 272 shares @ $14.6014, valued at $4k
Sold 4,493 shares @ $14.6014, valued at $65.6k
Sold 524 shares @ $14.5316, valued at $7.6k
Sold 8,672 shares @ $14.5316, valued at $126k
12/22/2010 4 Cole Douglas G. (Director) has filed a Form 4 on AVEO PHARMACEUTICALS INC
Txns: Sold 844 shares @ $14.2881, valued at $12.1k
Sold 13,956 shares @ $14.2881, valued at $199.4k
Sold 997 shares @ $14.6813, valued at $14.6k
Sold 16,503 shares @ $14.6813, valued at $242.3k
12/21/2010 4 Cole Douglas G. (Director) has filed a Form 4 on AVEO PHARMACEUTICALS INC
Txns: Sold 658 shares @ $14.0675, valued at $9.3k
Sold 10,891 shares @ $14.0675, valued at $153.2k
Sold 1,168 shares @ $14.1117, valued at $16.5k
Sold 19,332 shares @ $14.1117, valued at $272.8k
12/17/2010 4 Cole Douglas G. (Director) has filed a Form 4 on AVEO PHARMACEUTICALS INC
Txns: Sold 422 shares @ $14.1389, valued at $6k
Sold 6,978 shares @ $14.1389, valued at $98.7k
Sold 656 shares @ $14.2111, valued at $9.3k
Sold 10,851 shares @ $14.2111, valued at $154.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy